Steven Sherman
MD
Professor and Chair of Endocrine Neoplasia
👥Biography 个人简介
Steven Sherman is a renowned endocrine oncologist at MD Anderson Cancer Center who has led multiple landmark clinical trials in differentiated thyroid cancer. He was a principal investigator on the DECISION trial that established sorafenib for RAI-refractory disease. His work spans molecular diagnostics, risk stratification, and systemic therapies for thyroid cancer. He has been instrumental in developing American Thyroid Association guidelines.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Steven Sherman 的研究动态
Follow Steven Sherman's research updates
留下邮箱，当我们发布与 Steven Sherman（MD Anderson Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment